Nasopharyngeal carcinoma with mastoid recurrence after concurrent chemoradiotherapy masquerading as acute otomastoiditis

Chih Yu Hu, Shiang Fu Huang, Wan Ling Ho, Wen Yu Chuang, Kai Chieh Chan*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

2 Scopus citations

Abstract

Nasopharyngeal cancer (NPC) with mastoid recurrence is extraordinarily rare, and its development is thought to involve the Eustachian tube. We herein report a case of NPC with mastoid recurrence masquerading as acute otomastoiditis with facial paralysis in a 60-year-old man 44 months after concurrent chemoradiotherapy. The diagnosis was confirmed by exploratory tympanomastoidectomy with biopsy and Epstein–Barr-encoding region (EBER) in situ hybridization. Distant liver metastasis was detected simultaneously, and the patient underwent salvage treatment. He died 15 months later. Despite the rarity of mastoid recurrence, clinicians should be vigilant in the differential diagnosis of mastoiditis in patients with NPC after radiotherapy. Tumor biopsy and EBER in situ hybridization can aid in the accurate diagnosis of this uncommon condition.

Original languageEnglish
Pages (from-to)754-757
Number of pages4
JournalAuris Nasus Larynx
Volume44
Issue number6
DOIs
StatePublished - 12 2017
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2016 Elsevier B.V.

Keywords

  • Epstein–Barr-encoding region (EBER)
  • In situ hybridization
  • Mastoid recurrence
  • Nasopharyngeal carcinoma (NPC)
  • Otomastoiditis

Fingerprint

Dive into the research topics of 'Nasopharyngeal carcinoma with mastoid recurrence after concurrent chemoradiotherapy masquerading as acute otomastoiditis'. Together they form a unique fingerprint.

Cite this